Dexcel Pharma is an international specialty pharmaceutical company.
Dexcel Pharma is Israel’s largest private pharmaceutical company. Founded in 1968, they develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio thatspans more than 55 branded and generic products in over 140 dosage forms, our products are sold in the US, the UK, and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worldwide.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 13, 2018
Roivant Sciences
|
Private Equity(PE) | $200M | Biopharma | — |
May 1, 2014
Roivant Sciences
|
Private Equity(PE) | $93M | Biopharma | — |